Shandong Xinhua Pharmaceutical Company Limited (XIN) — Free Cash Flow Generation Index
Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Free Cash Flow Generation Index of -0.44x as of September 2023. Free cash flow of €-24.58 Million represents 0% of operating cash flow (€56.11 Million). Explore Shandong Xinhua Pharmaceutical Company L capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shandong Xinhua Pharmaceutical Company Limited Free Cash Flow Generation Index (2013–2025)
Historical FCF Generation Index trend for Shandong Xinhua Pharmaceutical Company Limited across 13 annual periods. For the full cash flow conversion analysis, see Shandong Xinhua Pharmaceutical Company L cash flow conversion.
Annual Free Cash Flow Generation for Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
Year-by-year Free Cash Flow Generation Index for Shandong Xinhua Pharmaceutical Company Limited. Check XIN total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | €418.13 Million | €533.73 Million | €115.60 Million | ▲ +85.6% |
| 2024 | 0.42x | €155.19 Million | €367.61 Million | €212.42 Million | ▲ +287.1% |
| 2023 | -0.23x | €-59.85 Million | €265.28 Million | €325.13 Million | ▼ -133.3% |
| 2022 | 0.68x | €513.48 Million | €758.24 Million | €244.76 Million | ▲ +1674.3% |
| 2021 | 0.04x | €9.89 Million | €259.12 Million | €249.23 Million | ▼ -88.5% |
| 2020 | 0.33x | €140.00 Million | €420.19 Million | €280.19 Million | ▲ +736.1% |
| 2019 | -0.05x | €-18.24 Million | €348.27 Million | €366.51 Million | ▲ +59.0% |
| 2018 | -0.13x | €-41.38 Million | €323.91 Million | €388.44 Million | ▼ -138.7% |
| 2017 | 0.33x | €128.86 Million | €389.97 Million | €261.11 Million | ▼ -78.2% |
| 2016 | 1.52x | €666.42 Million | €439.35 Million | €227.07 Million | ▲ +2.1% |
| 2015 | 1.48x | €517.72 Million | €348.64 Million | €169.09 Million | ▼ -15.2% |
| 2014 | 1.75x | €606.51 Million | €346.34 Million | €260.17 Million | ▼ -59.1% |
| 2013 | 4.28x | €449.52 Million | €104.99 Million | €344.53 Million | — |